Company Overview and News
MIRAMAR, Fla., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Spirit Airlines, Inc. (NYSE: SAVE) announced today that its board of directors has promoted Scott M. Haralson to the position of Senior Vice President and Chief Financial Officer (CFO) effective October 16, 2018. Haralson has over 18 years of airline experience and most recently served as Spirit’s Vice President of Financial Planning and Analysis and Corporate Real Estate.
2018-10-17 marketwatch - 1
Airline stocks are getting a big boost in premarket trade Wednesday, as better-than-expected earnings from UnitedContinental Holdings Inc. UAL, +5.66% in the wake of Delta Air Lines Inc.'s DAL, +2.52% upbeat results last week, provided a bout of optimism for the host of companies reporting next week. United's stock soared 5.7% ahead of the open, after reporting results late Tuesday, while Delta shares surged 3.
AAL SAVE DAL ALK
Wall Street commenced trading in October on a negative note following a robust third-quarter 2018. Rising yields on government bonds and trade-related conflicts with China are major issues, which in turn are leading to volatility. However, the recent stock market volatility may be transitory in nature, given the strong economic fundamentals of the United States. Whatever may be the fact, investors should be prepared to minimize fluctuations in their portfolio and rebalance it with suitable financial assets to maintain stability.
HII RNR WDR SAVE
Ryanair Holdings plc (RYAAY - Free Report) has been grappling with labor unrest since the time it acknowledged trade unions last December. The problem intensified this July when it witnessed the first-ever pilot strike in its home market of Ireland over its alleged failure to meet demands regarding new working practices. Since then, several walkouts by pilots and the cabin crew have taken place across the European countries of Spain, Belgium, Sweden, Holland, Portugal, Italy and Germany, resulting in numerous flight cancellations and hampering bookings in turn.
UNP RYAOF SAVE CSX RYAAY
Recently appointed chief operating officer (COO) at GoAir, Jyri Strandman, has quit the airline, adding to the spate of resignations at the Wadia Group promoted budget carrier. Strandman’s exit will be the seventh exit of senior level executives in the last three months.
Spirit Airlines has become the latest airline to impose additional restrictions on emotional support animals, the discount carrier announced this week.
American Airlines Group Inc.’s (AAL - Free Report) performance with respect to total revenue per available seat miles (TRASM: a key measure of unit revenues) is encouraging. The company expects TRASM to increase in the band of 1-3% during the third quarter of 2018. The upside can be attributed to strong demand for air travel, benefiting the entire airline industry. The company’s measures to counter challenges posed by high fuel prices are also impressive.
LMT UNP AAL SAVE CSX UTX
MIRAMAR, Fla., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Orlando is seeing even more yellow with a massive expansion by Florida’s hometown airline! Spirit Airlines (NYSE: SAVE) celebrates its first day of international service out of Orlando International Airport (MCO) by announcing it will bring hundreds of new jobs to the Orlando area with a new crew base for Flight Attendants and Pilots.
2018-10-03 investorplace - 1
U.S. equities traded mixed on Tuesday, with European stocks under pressure amid renewed focus on Italy’s shaky fiscal position. At the sector level, weakness in the Nasdaq Composite and transport stocks was seen initially before buyers swooped back in and cut the losses. Bank stocks continue to languish as Treasury yields drift lower. But it’s airline stocks that caught my eye today, with the entire industry group under pressure from rising energy price.
UAL AAL JBLU SAVE BA DAL ALK LUV
United Continental Holdings, Inc.’s (UAL - Free Report) wholly owned subsidiary United Airlines has introduced additional flights on its transcontinental routes connecting New York/Newark with Los Angeles and San Francisco. Additionally, the carrier will utilize its Boeing 787-10 model — the latest Dreamliner aircraft — on a few of its transcontinental flights between New York/Newark and Los Angeles and those between New York/Newark and San Francisco, effective Jan 7, 2019.
UAL SAVE TRN WERN
Ryanair Holdings plc (RYAAY - Free Report) has trimmed its guidance for fiscal 2019 due to rising oil prices, higher EU261 costs and back-to-back strikes. Bearish FY19 View The carrier now anticipates full-year profit (excluding Laudamotion) in the range of €1.10-€1.20 billion (previous outlook was in the band of €1.25-€1.35 billion). Ryanair gauged that the two recent strikes across five European countries will adversely impact the second quarter and third- quarter traffic and fares.
RYAOF SAVE RYAAY TRN WERN
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
as of ET